Similar articles

• A novel approach for establishing cardiovascular drug efficacy.

  Heerspink HJ, Grobbee DE, de Zeeuw D. Heerspink HJ, et al. Nat Rev Drug Discov. 2014 Dec;13(12):942. doi: 10.1038/nrd4090-c2. Epub 2014 Nov 14. Nat Rev Drug Discov. 2014. PMID: 25398246 No abstract available.
• Polypill-Based Therapy: A Promising Therapeutic Strategy.

  Luo F, Guo Y, Peng R, Ruan G, Li X. Luo F, et al. Heart Lung Circ. 2017 May;26(5):423-424. doi: 10.1016/j.hlc.2017.02.004. Epub 2017 Mar 6. Heart Lung Circ. 2017. PMID: 28320637 No abstract available.
• [Drug therapy in advanced age].

  Scholz H. Scholz H. Med Monatsschr Pharm. 1996 May;19(5):132-9. Med Monatsschr Pharm. 1996. PMID: 8684309 Review. German. No abstract available.
• President's Page: ISCP's educational goals.

  Cohn JN. Cohn JN. Cardiovasc Drugs Ther. 2010 Feb;24(1):89. doi: 10.1007/s10557-010-6216-1. Cardiovasc Drugs Ther. 2010. PMID: 20112058 No abstract available.
• Considerations for medication administration in the NPO patient.

  Byer H, Clifton GD. Byer H, et al. Prog Cardiovasc Nurs. 2000 Spring;15(2):63-6. doi: 10.1111/j.0889-7204.2000.080391.x. Prog Cardiovasc Nurs. 2000. PMID: 10804597 Review. No abstract available.